PL365879A1 - Improved specificity in treatment of diseases - Google Patents

Improved specificity in treatment of diseases

Info

Publication number
PL365879A1
PL365879A1 PL00365879A PL36587900A PL365879A1 PL 365879 A1 PL365879 A1 PL 365879A1 PL 00365879 A PL00365879 A PL 00365879A PL 36587900 A PL36587900 A PL 36587900A PL 365879 A1 PL365879 A1 PL 365879A1
Authority
PL
Poland
Prior art keywords
diseases
treatment
improved specificity
specificity
improved
Prior art date
Application number
PL00365879A
Other languages
English (en)
Polish (pl)
Inventor
Johnson Lau
Zhi Hong
Chin-Chung Lin
Original Assignee
Ribapharm Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc. filed Critical Ribapharm Inc.
Publication of PL365879A1 publication Critical patent/PL365879A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
PL00365879A 2000-08-22 2000-12-07 Improved specificity in treatment of diseases PL365879A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22687000P 2000-08-22 2000-08-22
US22687100P 2000-08-22 2000-08-22
US22694800P 2000-08-22 2000-08-22

Publications (1)

Publication Number Publication Date
PL365879A1 true PL365879A1 (en) 2005-01-10

Family

ID=27397667

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00365879A PL365879A1 (en) 2000-08-22 2000-12-07 Improved specificity in treatment of diseases

Country Status (15)

Country Link
EP (1) EP1351966A1 (xx)
JP (1) JP2004518618A (xx)
KR (1) KR20030040415A (xx)
CN (1) CN1460109A (xx)
AU (1) AU2001220806A1 (xx)
BR (1) BR0017318A (xx)
CA (1) CA2416748A1 (xx)
CZ (1) CZ2003460A3 (xx)
HU (1) HUP0302882A3 (xx)
IL (1) IL154168A0 (xx)
MX (1) MXPA03001528A (xx)
NO (1) NO20030762L (xx)
PL (1) PL365879A1 (xx)
TW (1) TW200414903A (xx)
WO (1) WO2002016382A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE29835E (en) * 1971-06-01 1978-11-14 Icn Pharmaceuticals 1,2,4-Triazole nucleosides
US3991078A (en) * 1971-06-01 1976-11-09 Icn Pharmaceuticals, Inc. N-substituted 1,2,4-triazoles
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US4093624A (en) * 1977-01-31 1978-06-06 Icn Pharmaceuticals, Inc. 1,2,4-Thiadiazolidine-3,5-dione
JPS6426593A (en) * 1987-07-21 1989-01-27 Asahi Glass Co Ltd Nucleoside derivative
US4925930A (en) * 1988-11-02 1990-05-15 Nucleic Acid Research Institute Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates

Also Published As

Publication number Publication date
CZ2003460A3 (cs) 2003-10-15
CN1460109A (zh) 2003-12-03
NO20030762D0 (no) 2003-02-18
CA2416748A1 (en) 2002-02-28
HUP0302882A3 (en) 2005-06-28
NO20030762L (no) 2003-04-22
BR0017318A (pt) 2004-06-15
MXPA03001528A (es) 2004-04-02
AU2001220806A1 (en) 2002-03-04
IL154168A0 (en) 2003-07-31
KR20030040415A (ko) 2003-05-22
HUP0302882A2 (hu) 2003-12-29
JP2004518618A (ja) 2004-06-24
TW200414903A (en) 2004-08-16
EP1351966A1 (en) 2003-10-15
WO2002016382A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
EP1267798A4 (en) TREATMENT OF SKIN DAMAGE WITH POLYENYLPHOSPHATIDYLCHOLINE
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
GB0015745D0 (en) Treatment of bone diseases
GB0020351D0 (en) Treatment of hyperproliferative diseases
AU5464601A (en) Treatment of scale
AU5040101A (en) Improved treatment of neovascularization
GB0001710D0 (en) Therapeutic treatment
AU5000001A (en) Treatment of vitiligo
GB2360453B (en) Treatment of skin conditions
HUP0302882A3 (en) Improved specificity in treatment of diseases
AU2096002A (en) Therapeutic treatment
GB0012186D0 (en) Treatment of cancer and neurological diseases
IL154011A0 (en) Treatment of wounds
GB2381455B (en) Treatment of burns
EP1303281A4 (en) METHODS OF TREATMENT
AU1324002A (en) Treatment of demyelinating diseases
GB0014904D0 (en) Methods of treatment
GB0013928D0 (en) Methods of treatment
AU8679801A (en) Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
IL153788A0 (en) Treatment of eating disorders using carboxyalkylethers
GB0016197D0 (en) Treatment and prevention of disease
GB0030866D0 (en) Treatment and prevention of disease
GB0030865D0 (en) Treatment and prevention of disease
GB0003228D0 (en) Treatment of GI disorders

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)